Clinical Trial Update: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating human umbilical cord-derived mesenchymal stem cells for decompensated cirrhosis is currently recruiting at Beijing 302 Hospita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis

Drugs mentioned

• Human Umbilical Cord-derived Mesenchymal Stem Cells (hUC-MSCs) (mesenchymal stem cells)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Decompensated Cirrhosis | Phase 2 | Status: RECRUITING